Zhi‐Ling Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
Papers in
-
- RNA modifications and cancer 4
- Glycosylation and Glycoproteins Research 2
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Co-authors
- Rong Deng (20 shared papers)Yun Huang (13 shared papers)Gong‐Kan Feng (13 shared papers)Xiao‐Feng Zhu (14 shared papers)Yuhong Chen (10 shared papers)Xiao-Dan Peng (7 shared papers)Bingxin Hu (8 shared papers)Hai‐Liang Zhang (6 shared papers)
- Journals
- Nature Communications (4 papers)BioMed Research International (2 papers)Theranostics (2 papers)Bioactive Materials (1 paper)IUBMB Life (1 paper)
- Partner nations
- ChinaUnited StatesMexico
In The Last Decade
Zhi‐Ling Li
38 papers receiving 1.6k citations
Zhi‐Ling Li's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 432
- Pulmonary and Respiratory Medicine 475
- Molecular Biology 844
- Oncology 293
- Immunology 229
Countries citing papers authored by Zhi‐Ling Li
This map shows the geographic impact of Zhi‐Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Ling Li more than expected).
Fields of papers citing papers by Zhi‐Ling Li
This network shows the impact of papers produced by Zhi‐Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Ling Li. The network helps show where Zhi‐Ling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhi‐Ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis Hit paper breakdown → | 2022 | 432 |
| 2 | 2020 | 161 | |
| 3 | 2020 | 140 | |
| 4 | 2021 | 131 | |
| 5 | 2021 | 99 | |
| 6 | 2019 | 85 | |
| 7 | 2021 | 64 | |
| 8 | 2020 | 50 | |
| 9 | 2018 | 46 | |
| 10 | 2020 | 42 | |
| 11 | 2020 | 41 | |
| 12 | 2024 | 40 | |
| 13 | 2019 | 31 | |
| 14 | 2016 | 25 | |
| 15 | 2021 | 22 | |
| 16 | 2017 | 17 | |
| 17 | 2023 | 15 | |
| 18 | 2019 | 14 | |
| 19 | 2019 | 14 | |
| 20 | 2025 | 13 |
About Zhi‐Ling Li
Zhi‐Ling Li is a scholar working on Molecular Biology, Cancer Research, Immunology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 42 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (4 papers), Autophagy in Disease and Therapy (3 papers), MicroRNA in disease regulation (3 papers), Glycosylation and Glycoproteins Research (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Cancer Research (432 citations), Pulmonary and Respiratory Medicine (475 citations), Molecular Biology (844 citations), Oncology (293 citations) and Immunology (229 citations). Zhi‐Ling Li has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Rong Deng, Yun Huang, Gong‐Kan Feng, Xiao‐Feng Zhu, Yuhong Chen, Xiao-Dan Peng, Bingxin Hu, Hai‐Liang Zhang, Tian Du and Zhipeng Ye. Their work appears in journals such as Nature Communications, BioMed Research International, Theranostics, Bioactive Materials and IUBMB Life.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.